HIM
IRWD icon

Hillsdale Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Hillsdale Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.34M Buy
1,236,628
+80,250
+7% +$329K 0.12% 222
2025
Q4 		$3.9M Buy
+1,156,378
New +$3M 0.11% 257
2024
Q3 		– Sell
-164,800
Closed -$1.07M – 655
2024
Q2 		$1.07M Sell
164,800
-6,400
-4% -$45.3K 0.08% 215
2024
Q1 		$1.49M Buy
171,200
+13,800
+9% +$167K 0.12% 192
2023
Q4 		$1.8M Buy
+157,400
New +$1.56M 0.15% 189
2023
Q3 		– Sell
-424,017
Closed -$4.51M – 610
2023
Q2 		$4.51M Buy
424,017
+3,400
+0.8% +$36.5K 0.41% 78
2023
Q1 		$4.42M Hold
420,617
– – 0.38% 94
2022
Q4 		$5.21M Buy
420,617
+1,700
+0.4% +$19.3K 0.44% 61
2022
Q3 		$4.34M Buy
418,917
+84,400
+25% +$957K 0.39% 91
2022
Q2 		$3.86M Sell
334,517
-2,000
-0.6% -$23.6K 0.31% 122
2022
Q1 		$4.23M Sell
336,517
-3,100
-0.9% -$35.5K 0.27% 128
2021
Q4 		$3.96M Sell
339,617
-1,000
-0.3% -$12.3K 0.27% 132
2021
Q3 		$4.45M Buy
340,617
+38,000
+13% +$491K 0.34% 96
2021
Q2 		$3.9M Hold
302,617
– – 0.31% 114
2021
Q1 		$3.38M Buy
+302,617
New +$3.2M 0.28% 126
2013
Q3 		– Sell
-5,492
Closed -$46K – 542
2013
Q2 		$46K Buy
+5,492
New +$66.6K 0.02% 436

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Hillsdale Investment Management's IRWD Position: Q1 2026 in Review

Hillsdale Investment Management increased its Ironwood Pharmaceuticals (IRWD) stake by 6.9% in Q1 2026, buying an estimated $329K and bringing the position to 1,236,628 shares worth $4.34M. The position accounts for 0.12% of the portfolio, ranked #222.

Hillsdale Investment Management first reported a position in IRWD in Q2 2013 and has held it in 16 quarters since. The position peaked at $5.21M in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Hillsdale Investment Management held 1,236,628 shares of Ironwood Pharmaceuticals worth $4.34M as of Q1 2026.
  • Hillsdale Investment Management bought 80,250 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $329K.
  • Ironwood Pharmaceuticals made up 0.12% of Hillsdale Investment Management's portfolio in Q1 2026, its #222 holding.
  • Hillsdale Investment Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Hillsdale Investment Management's Ironwood Pharmaceuticals position peaked at $5.21M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.